Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam
As a response to the coronavirus disease 2019 (COVID-19) pandemic, Vietnam enforced strict quarantine, contact tracing and physical distancing policies resulting in one of the lowest numbers of individuals infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) globally. This study aimed to determine the prevalence of SARS-CoV-2 antibody positivity among high-risk populations in Vietnam. A prevalence survey was undertaken within four communities in Vietnam, where at least two COVID-19 cases had been confirmed. Participants were classified according to the location of exposure: household contacts, close contacts, community members, and healthcare workers (HCWs) responsible for treating COVID-19 cases. Participants completed a baseline questionnaire and SARS-CoV-2 IgG antibodies were quantified using a commercial assay. A total of 3049 community members and 149 health care workers consented to the study. Among 13 individuals who were seropositive (0.4%), five household contacts (5/27, 18.5%), one close contact (1/53, 1.9%), and seven community members (7/2954, 0.2%) had detectable SARS-CoV-2 antibodies. All HCWs were negative for SARS-CoV-2 antibodies. Participants were tested a median of 15.1 (interquartile range from 14.9 to 15.2) weeks after exposure. Our study found a low prevalence of SARS-CoV-2 antibodies in high-risk communities and healthcare workers in communities in Vietnam with known COVID-19 cases..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
International Journal of Environmental Research and Public Health - 18(2021), 6353, p 6353 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tasnim Hasan [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.3390/ijerph18126353 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ003578259 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ003578259 | ||
| 003 | DE-627 | ||
| 005 | 20230309175153.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijerph18126353 |2 doi | |
| 035 | |a (DE-627)DOAJ003578259 | ||
| 035 | |a (DE-599)DOAJ44edf1e8f80b4061b77420f722d36637 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Tasnim Hasan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a As a response to the coronavirus disease 2019 (COVID-19) pandemic, Vietnam enforced strict quarantine, contact tracing and physical distancing policies resulting in one of the lowest numbers of individuals infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) globally. This study aimed to determine the prevalence of SARS-CoV-2 antibody positivity among high-risk populations in Vietnam. A prevalence survey was undertaken within four communities in Vietnam, where at least two COVID-19 cases had been confirmed. Participants were classified according to the location of exposure: household contacts, close contacts, community members, and healthcare workers (HCWs) responsible for treating COVID-19 cases. Participants completed a baseline questionnaire and SARS-CoV-2 IgG antibodies were quantified using a commercial assay. A total of 3049 community members and 149 health care workers consented to the study. Among 13 individuals who were seropositive (0.4%), five household contacts (5/27, 18.5%), one close contact (1/53, 1.9%), and seven community members (7/2954, 0.2%) had detectable SARS-CoV-2 antibodies. All HCWs were negative for SARS-CoV-2 antibodies. Participants were tested a median of 15.1 (interquartile range from 14.9 to 15.2) weeks after exposure. Our study found a low prevalence of SARS-CoV-2 antibodies in high-risk communities and healthcare workers in communities in Vietnam with known COVID-19 cases. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a seroprevalence | |
| 650 | 4 | |a Vietnam | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Thach Ngoc Pham |e verfasserin |4 aut | |
| 700 | 0 | |a Thu Anh Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Hien Thi Thu Le |e verfasserin |4 aut | |
| 700 | 0 | |a Duyet Van Le |e verfasserin |4 aut | |
| 700 | 0 | |a Thuy Thi Dang |e verfasserin |4 aut | |
| 700 | 0 | |a Trang Dinh Van |e verfasserin |4 aut | |
| 700 | 0 | |a Yen Ngoc Pham |e verfasserin |4 aut | |
| 700 | 0 | |a Ha Viet Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Giang Linh Tran |e verfasserin |4 aut | |
| 700 | 0 | |a Van Thi Cam Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Thanh Trung Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Viet Quang Truong |e verfasserin |4 aut | |
| 700 | 0 | |a Than Huu Dao |e verfasserin |4 aut | |
| 700 | 0 | |a Chung Thanh Le |e verfasserin |4 aut | |
| 700 | 0 | |a Nam Tan Truong |e verfasserin |4 aut | |
| 700 | 0 | |a Hoang Trung Vo |e verfasserin |4 aut | |
| 700 | 0 | |a Phuc Thanh Le |e verfasserin |4 aut | |
| 700 | 0 | |a Thao Thanh Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Vinh Van Luu |e verfasserin |4 aut | |
| 700 | 0 | |a Vinh Dai Nguyen |e verfasserin |4 aut | |
| 700 | 0 | |a Brett G. Toelle |e verfasserin |4 aut | |
| 700 | 0 | |a Guy B. Marks |e verfasserin |4 aut | |
| 700 | 0 | |a Greg J. Fox |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Environmental Research and Public Health |d MDPI AG, 2005 |g 18(2021), 6353, p 6353 |w (DE-627)DOAJ000006807 |x 16604601 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2021 |g number:6353, p 6353 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijerph18126353 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/44edf1e8f80b4061b77420f722d36637 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/1660-4601/18/12/6353 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1661-7827 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1660-4601 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2021 |e 6353, p 6353 | ||